Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGAIN: Regulatory T Cells in Autism and Maternal Immune Activation
NCT06169111Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Regulatory T cells count (% CD4+) at Day 1, Th17 lymphocytes count (% CD3+) at Day 1 and 1 more. Planned start Jan 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06169111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06169111.